NL
AMPH icon

NVWM LLC’s Amphastar Pharmaceuticals AMPH Stock Holding History

NVWM LLC’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-627
Closed -$23.3K – 653
2024
Q4 		$23.3K Buy
627
+201
+47% +$9.19K 0.01% 267
2024
Q3 		$20.7K Buy
426
+18
+4% +$790 0.01% 277
2024
Q2 		$16.3K Buy
408
+54
+15% +$2.24K ﹤0.01% 284
2024
Q1 		$15.5K Sell
354
-9
-2% -$465 ﹤0.01% 287
2023
Q4 		$22.5K Buy
363
+179
+97% +$9.4K 0.01% 270
2023
Q3 		$8.46K Buy
+184
New +$10K ﹤0.01% 327

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NVWM LLC's AMPH Position: Q1 2025 in Review

NVWM LLC sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 627 shares — an estimated $23.3K sold.

NVWM LLC first reported a position in AMPH in Q3 2023 and held it in 6 quarters. The position peaked at $23.3K in Q4 2024. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

  • NVWM LLC reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • NVWM LLC sold 627 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $23.3K.
  • NVWM LLC first reported a position in Amphastar Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • NVWM LLC's Amphastar Pharmaceuticals position peaked at $23.3K in Q4 2024.
  • 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on NVWM LLC's 13F filing for Q1 2025, filed 7 May 2025.